Decrease in Brain Cytochrome P450 Enzyme Activities during Infection and Inflammation of the Central Nervous System

2000 ◽  
Vol 8 (3) ◽  
pp. 142-147 ◽  
Author(s):  
Mario Monshouwer ◽  
Davide Agnello ◽  
Pietro Ghezzi ◽  
Pia Villa
1993 ◽  
Vol 47 (1-6) ◽  
pp. 191-194 ◽  
Author(s):  
Margaret Warner ◽  
Maria Strömstedt ◽  
Adrian Wyss ◽  
Jan-Åke Gustafsson

2019 ◽  
Vol 34 (1) ◽  
pp. S25
Author(s):  
Maciej Czerwinski ◽  
Brian Oberheide ◽  
Nicholas Hatfield ◽  
Bill Ewy ◽  
Christopher Seib ◽  
...  

Pharmacology ◽  
2015 ◽  
Vol 95 (3-4) ◽  
pp. 145-153 ◽  
Author(s):  
Bingbing Chen ◽  
Peipei Pan ◽  
Li Wang ◽  
Menchun Chen ◽  
Yaoyao Dong ◽  
...  

2013 ◽  
Vol 59 ◽  
pp. 78-85 ◽  
Author(s):  
Yu Fen Zheng ◽  
Soo Hyeon Bae ◽  
Min Jo Kwon ◽  
Jung Bae Park ◽  
Hye Duck Choi ◽  
...  

2019 ◽  
Vol 2019 (4) ◽  
Author(s):  
Kathryn Burns ◽  
Nuala Ann Helsby

The cytochrome P450 enzyme family (CYP450), E.C. 1.14.-.-, were originally defined by their strong absorbance at 450 nm due to the reduced carbon monoxide-complexed haem component of the cytochromes. They are an extensive family of haem-containing monooxygenases with a huge range of both endogenous and exogenous substrates. These include sterols, fat-soluble vitamins, pesticides and carcinogens as well as drugs. The substrates of some orphan CYP are not known. Listed below are the human enzymes; their relationship with rodent CYP450 enzyme activities is obscure in that the species orthologue may not catalyse the metabolism of the same substrates. Although the majority of CYP450 enzyme activities are concentrated in the liver, the extrahepatic enzyme activities also contribute to patho/physiological processes. Genetic variation of CYP450 isoforms is widespread and likely underlies a significant proportion of the individual variation to drug administration.


2020 ◽  
Vol 10 (4) ◽  
pp. 219-222 ◽  
Author(s):  
Cezar Thomas R Suratos ◽  
Mark M Del Rosario ◽  
Roland Dominic G Jamora

Serotonin syndrome is due to excess serotonin in the nervous system. We document a case of an elderly Parkinson disease patient who has been neurologically stable on rasagiline and escitalopram for 1 year but developed serotonin syndrome after intake of an ethanol-containing homeopathic medication. The patient presented with seizures, autonomic dysfunction and neuromuscular hyperexcitability. Maintenance medications were discontinued, hydration, sedation and respiratory support were provided with resolution of the symptoms. The combination of escitalopram and ethanol, both metabolized by the cytochrome P450 enzyme system can lead to serotonin syndrome. Our case highlights the importance of drug interactions in patients taking several medications. Additionally, the intake of medicines, may it be conventional or homeopathic medicine, without the guidance of a trained and competent physician, may lead to serious consequences for the patient.


Sign in / Sign up

Export Citation Format

Share Document